Glucagon-like peptide-1 (GLP-1)

DIETARY_SUPPLEMENT2 trials

Sponsors

Oslo University Hospital, Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2Post-transplant Diabetes Mellitus

Unknown Phase

GLP-1 Effects on Insulin and Glucagon in PTDM

CompletedNCT02591849

Oslo University HospitalPost-transplant Diabetes Mellitus

Start: 2014-10-31End: 2015-03-31Updated: 2016-03-31

Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments

CompletedNCT04809311

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2024-04-30End: 2025-01-07Updated: 2025-03-21